Same Indication

Imatinib vs Montelukast

Imatinib vs Montelukast: Overview

This comparison examines the pharmacological differences between Imatinib and Montelukast.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Montelukast — 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O; Montelukast — C35H36ClNO3S.

Molecular Weight: Imatinib — 493.6030 g/mol; Montelukast — 586.1800 g/mol.

Type: Imatinib — Small molecule; Montelukast — Small molecule.